Posts

Showing posts from November, 2022

Department of Public Health - Acute Communicable Disease Control - Department of Public Health

About RSV Respiratory syncytial (sin-SISH-uhl) virus, or RSV, is a common respiratory virus that usually causes mild, cold-like symptoms. Most people recover in a week or two, but RSV can be serious, especially for infants, older adults and those with weakened immune systems. RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lung) and pneumonia (infection of the lungs) in children younger than 1 year of age in the United States. RSV circulation in the United States usually starts during fall and peaks in the winter. The timing and severity of RSV circulation can vary from year to year. Symptoms In most people, RSV causes a mild, cold-like illness that lasts for 1-2 weeks. Symptoms usually appear 4 to 6 days after getting infected. Symptoms of RSV infection usually include: Runny Nose ...

PT027 recommended by FDA Advisory Committee as new rescue treatment for asthma - AstraZeneca

9 November 2022 07:00 GMT   First and only rescue medication recommended for US approval that has been shown to reduce severe exacerbations   The Food and Drug Administration's (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) has voted 16 to 1 that the data support a favourable benefit risk assessment for the use of PT027 (albuterol/budesonide) for the treatment of asthma in people aged 18 years and older. In adolescents aged 12 to 17 years, the Committee voted 9 to 8 that the data do not support a favourable benefit risk assessment for the use of PT027 for the treatment of asthma. In children aged 4 to 11 years, the Committee voted 16 to 1 that the data do not support a favourable benefit risk assessment for the use of PT027 for the treatment of asthma. PT027 is a potential first-in-class, pressurised metered-dose inhaler (pMDI), fixed-dose combination rescue medication in the US containing albuterol, a short-acting beta2-agonist...

Freezing to death: What happens in the body? - Hindustan Times

Image
health Published on Nov 29, 2022 05:34 PM IST Winter has arrived in Ukraine, amplifying fears of the cold amid a war causing frequent energy blackouts. Here's what happens in the body when it freezes to death. Ukraine's capital city Kiev saw its first snow last week, ushering in a winter of stress and uncertainty(Roman Pilipey/EPA-EFE) By Deutsche Welle Our bodies require a core temperature of 36.5 to 37 degrees Celsius (97.7 to 98.6 degrees Fahrenheit). Although it does everything in its power to maintain that temperature, the body can only do so much on its own — more than five million people die every year due to freezing or excessively hot temperatures. {{^userSubscribed}} {{/userSubscribed}} {{^userSubscribed}} {{/userSubscribed}} Metabolism regulates body temperature The body regulates its core temperature through metabolism-activating receptors. To maintain the ideal level of warmth, the metabol...

La Niña winter ups and downs smack Michigan in next two weeks - MLive.com

Image
This winter has been forecasted to have larger-than-normal swings in the weather pattern. The next two weeks are going to fit that weather description exactly. In the next two weeks I see three strong warm-ups, two short-lived cool snaps and finally a longer lasting cold pattern settling in. The temperature anomaly forecast through Tuesday, December 13 shows the rapid ups and downs I'm talking about. Temperature anomaly forecast from Tuesday, November 29 to Tuesday, December 13 shows three sharp warm-ups and eventually a longer cold stretch. The temperature pattern over Michigan for the next two weeks goes like this: A strong warm-up today, November 29. A two-day blast of wind and chill Wednesday into Thursday. Another strong warm-up Friday and half of Saturday, followed by just Sunday on the cold side. Another quick warm-up next Monday. Then it appears as though there will finally be an extended period of colder-than-normal temperatures overtaking Michigan around Tuesday, December...

Benadryl for Asthma: Uses, Effectiveness, and Precautions - Healthline

Image
Some people with allergic asthma may find relief from using an antihistamine like Benadryl. But it's not a recommended asthma treatment. Asthma is a chronic respiratory condition that causes inflammation of the airways. When your airway passages narrow, it makes it harder to breathe. People with asthma often experience: There are two main types of asthma: allergic and non-allergic. Allergic asthma is caused by exposure to a substance that causes an allergic reaction. Common allergens for allergic asthma include mold, pet dander, pollen, and dust. Non-allergic asthma is unrelated to allergies and may be caused by stress, illness, weather, exercise, irritants in the air, and some medications. Some people with allergic asthma may find symptom relief from using an antihistamine like Benadryl if they also experience symptoms of allergic rhinitis. But it's not a recommended treatment for allergic asthma. Some people do take over-the-counter antihistamines for allergy symptoms. Benadr...

Al Rocker was 'admitted to hospital' following a life-threatening pulmonary embolism - Express

Image
The British Lung Foundation expanded on how inactivity is a risk factor for a pulmonary embolism. "When you're inactive, blood tends to collect in the lower parts of your body, particularly in your lower legs," the charity notes. "This isn't usually a problem because when you start to move, your blood flow increases, and blood begins to move more evenly round your body. "But if you're immobile for a long time, the flow of blood around your body can slow and clot.

Face masks and asthma: Safety, guidelines, and more - Medical News Today

Image
It is safe for people with asthma to wear face masks. It can protect them and others from COVID-19 and help to reduce asthma symptoms in cold weather. Asthma is a chronic lung condition that affects around 1 in 13 people in the United States. It makes the tubes that carry air in and out of the lungs swollen and narrow. People with asthma may wear a facemask for several reasons. These include: preventing the spread of viruses, including coronavirus easing asthma symptoms during cold weather protecting themselves or others at work in healthcare or construction settings There has been considerable debate on whether it is safe for people with asthma to wear a face mask. The concern has been that the mask could make it difficult to breathe. However, no evidence suggests that wearing a face mask can worsen asthma symptoms. In this article, we examine the evidence on mask safety for people with asthma. We also look at the benefits of wearing a mask with asthma and whether a mask may help dur...

Opinion | Covid, Flu, RSV: We Know How to Deal With Them. Will We? - The New York Times

Image
Before the Covid-19 pandemic, little was done beyond flu shots to counter the seasonal respiratory virus infections that circulate among the general public in a typical year — such as influenza viruses, coronaviruses, rhinoviruses and more. During the first two years of the pandemic, people largely got a reprieve from other viruses like flu and respiratory syncytial virus, also known as RSV. Many people went two years without getting sick, perhaps a first in their lifetime and certainly out of the ordinary for children. Outbreaks that did occur were much smaller than usual. Now, these viruses are back. Heading into winter, pediatricians and hospitals are reporting an influx of young patients with RSV. Flu cases are spiking. But why did these viruses disappear in the first place? And what does this mean for the cold and flu season? Will there be a "tripledemic" this winter? Amid the holiday season, understanding the dynamics of how viruses surge and plunge helps explain why so...

Benadryl for Asthma: Uses, Effectiveness, and Precautions - Healthline

Image
Some people with allergic asthma may find relief from using an antihistamine like Benadryl. But it's not a recommended asthma treatment. Asthma is a chronic respiratory condition that causes inflammation of the airways. When your airway passages narrow, it makes it harder to breathe. People with asthma often experience: There are two main types of asthma: allergic and non-allergic. Allergic asthma is caused by exposure to a substance that causes an allergic reaction. Common allergens for allergic asthma include mold, pet dander, pollen, and dust. Non-allergic asthma is unrelated to allergies and may be caused by stress, illness, weather, exercise, irritants in the air, and some medications. Some people with allergic asthma may find symptom relief from using an antihistamine like Benadryl if they also experience symptoms of allergic rhinitis. But it's not a recommended treatment for allergic asthma. Some people do take over-the-counter antihistamines for allergy symptoms. Benadr...

5 of the best inhalers for asthma - Medical News Today

Image
We include products we think are useful for our readers. If you buy through links on this page, we may earn a small commission. Here's our process. Asthma is a condition where the airways constrict, leading to breathing difficulties. People with asthma may use inhalers to deliver medication to the airways to avoid asthma attacks or to relieve symptoms during an attack. Quick links Asthma medication helps alleviate the symptoms of the condition by using bronchodilators to relax the muscles in the airways, and anti-inflammatories to reduce swelling and mucus. Bronchodilators can be either short- or long-acting. Short-acting inhalers, which people may also call quick-relief or rescue inhalers, provide short-term relief for sudden asthma symptoms. Long-acting inhalers, on the other hand, can help prevent asthma symptoms. A person will usually need to use these inhalers daily. Doctors may prescribe one or both types of bronchodilators in inhaler forms. An individual can also purchase ov...

New mechanical thrombectomy systems unlock possibilities for the treatment of venous thromboembolism - Vascular News

Image
 Gerd Grözinger (Tübingen, Germany) chats with Bernhard Gebauer (Berlin, Germany) at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2022 annual meeting (10–14 September, Barcelona, Spain) about some of the difficulties associated with treating patients with pulmonary embolism (PE) and deep vein thrombosis (DVT). Gebauer states that "the options we have at the moment with either anticoagulation or lysis are very limited". One of the problems with systemic thrombolysis for example, explains Gebauer, is that "you could have some complications" with the high dose, in addition to the fact that lysis "is contraindicated in a lot of patients". Grözinger agrees with Gebauer that the age of the thrombus is very important. Asked about the perfect time window to treat those with DVT, Grözinger states that "in the old days we had to tell our patients that beyond two to four weeks there is no chance of getti...

Bronchiolitis Obliterans Syndrome Pipeline Drugs and Companies Insight Report (2022): Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments - Digital Journal

Image
Bronchiolitis Obliterans Syndrome pipeline constitutes 5+ key companies continuously working towards developing 10+ Bronchiolitis Obliterans Syndrome treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. Bronchiolitis Obliterans Syndrome Overview Bronchiolitis Obliterans Syndrome (BOS) is a form of chronic lung allograft dysfunction that affects a majority of lung transplant recipients and is the principal factor limiting long-term transplant survival. BOS is characterized by progressive airflow obstruction unexplained by acute rejection, infection, or other coexistent condition. Although BOS is a proven useful clinical syndrome that identifies patients at increased risk for death, its clinical course and underlying causative factors are now recognized to be increasingly heterogeneous. "Bronchiolitis Obliterans Syndrome Pipeline Insight, 2022" report by DelveInsight outli...